News | September 23, 2024
Ind Swift Laboratories opens marketing office in New Delhi
This office will be the central hub for all operations related to companies ethical pharmaceutical business
This office will be the central hub for all operations related to companies ethical pharmaceutical business
Stable profits, low leverage to keep credit profiles comfortable
Takeda has granted Lupin non-exclusive patent licensing rights to commercialize Vonoprazan in India
The companies will combine Nanoform’s Biologics platform with the Celanese VitalDose Drug Delivery platform to further optimize controlled release of biologics
Chobhe brings over 30 years of extensive experience in quality and regulatory management within the pharmaceutical industry
The new Injectable Facility housed in Akums Healthcare started commercial production on 22nd August 2024, with a capacity of 362 million units annually
Sigachi's entry into the coatings market is strategically timed to capitalize on the industry's growth potential
Collaboration with KNAUER to streamline and improve the scale-up of LNP formulations
Capital expenditure expected to moderate to Rs. 5.6 billion in FY2025 from an estimated Rs. 7.6 billion in FY2024
This project is supported by the Irish Government through IDA Ireland
Subscribe To Our Newsletter & Stay Updated
